NCT01199315View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 After Oral Single and Repeated Doses

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Healthy
Interventions
DRUG

AZD1446

oral capsule, Moderate Release

DRUG

Placebo

oral capsule

Trial Locations (1)

Unknown

Research Site, Fukuoka

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY